Resistance to Single-agent Chemotherapy for Low-risk Gestational Trophoblastic Neoplasia

Resistance to Single-agent Chemotherapy for Low-risk Gestational Trophoblastic Neoplasia

Background: Methotrexate (MTX) and actinomycin D (ActD) have been used as first-line chemotherapy agents in the treatment of low-risk gestational trophoblastic neoplasia (GTN). Although low-risk GTN is considered a curable disease, its reported primary remission rates of 49 to 93% reflect the diffic...

Full description

Bibliographic Details
Main Authors: Shahrzad Sheikhhasani, Aghdas Abdolrazaghnejad, Azam sadat Mousavi, Setareh Akhavan, Narges Zamani, Elham Feizabad
Format: Article
Language:English
Published: Babol University of Medical Sciences 2023-01-01
Series:Caspian Journal of Internal Medicine
Subjects:
single-agent chemotherapy
gestational trophoblastic neoplasia
dactinomycin
methotrexate
treatment failure
Online Access:http://caspjim.com/article-1-3295-en.html

Internet

http://caspjim.com/article-1-3295-en.html

Similar Items